Acceder

Publicaciones - Control molecular de la proliferación y diferenciación

Cargando...
Pladevall-Morera D, Castejon-Grinan M, Aguilera P, Gaardahl K, Ingham A, Brosnan-Cashman JA, Meeker AK, Lopez-Contreras AJ. ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors. Cancers (Basel). 2022 Mar 31;14(7):1790. doi: 10.3390/cancers14071790. PubMed PMID: 35406561; PubMed Central PMCID: PMC8997088.
AÑO: 2022; IF: 4.5
Stefanaki I, Stratigos AJ, Kypreou KP, Evangelou E, Gandini S, Maisonneuve P, Polsky D, Lazovich D, Newton-Bishop J, Kanetsky PA, Puig S, Gruis NA, Ghiorzo P, Pellegrini C, De Nicolo A, Ribas G, Guida G, Garcia-Borron JC, Fargnoli MC, Nan H, Landi MT, Little J, Sera F, Raimondi S; M-SKIP Study Group. MC1R variants in relation to naevi in melanoma cases and controls: a pooled analysis from the M-SKIP project. J Eur Acad Dermatol Venereol. 2021 Feb;35(2):e135-e138. doi: 10.1111/jdv.16869. Epub 2020 Sep 6. No abstract available. PubMed PMID: 32780924; PubMed Central PMCID: PMC8327925.
AÑO: 2021; IF: 9.228
Sires-Campos J, Lambertos A, Delevoye C, Raposo G, Bennett DC, Sviderskaya E, Jimenez-Cervantes C, Olivares C, Garcia-Borron JC. Mahogunin Ring Finger 1 regulates pigmentation by controlling the pH of melanosomes in melanocytes and melanoma cells. Cell Mol Life Sci. 2021 Dec 18;79(1):47. doi: 10.1007/s00018-021-04053-9. PubMed PMID: 34921635; PubMed Central PMCID: PMC8738503.
AÑO: 2021; IF: 9.207
Herraiz C, Martinez-Vicente I, Maresca V. The alpha-melanocyte-stimulating hormone/melanocortin-1 receptor interaction: A driver of pleiotropic effects beyond pigmentation. Pigment Cell Melanoma Res. 2021 Jul;34(4):748-761. doi: 10.1111/pcmr.12980. Epub 2021 May 2. PubMed PMID: 33884776.
AÑO: 2021; IF: 4.159
Martinez-Vicente I, Abrisqueta M, Herraiz C, Sires-Campos J, Castejon-Grinan M, Bennett DC, Olivares C, Garcia-Borron JC, Jimenez-Cervantes C. Mahogunin Ring Finger 1 Is Required for Genomic Stability and Modulates the Malignant Phenotype of Melanoma Cells. Cancers (Basel). 2020 Oct 1;12(10):2840. doi: 10.3390/cancers12102840. PubMed PMID: 33019669; PubMed Central PMCID: PMC7599452.
AÑO: 2020; IF: 6.575
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII

Control molecular de la proliferación y diferenciación